These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 1553250)
1. Detection of contamination with antineoplastic agents in a hospital pharmacy department. Sessink PJ; Anzion RB; Van den Broek PH; Bos RP Pharm Weekbl Sci; 1992 Feb; 14(1):16-22. PubMed ID: 1553250 [TBL] [Abstract][Full Text] [Related]
2. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019 [TBL] [Abstract][Full Text] [Related]
3. Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques. Harrison BR; Peters BG; Bing MR Am J Health Syst Pharm; 2006 Sep; 63(18):1736-44. PubMed ID: 16960258 [TBL] [Abstract][Full Text] [Related]
4. The assessment of environmental and external cross-contamination in preparing ready-to-administer cytotoxic drugs: a comparison between a robotic system and conventional manual production. Werumeus Buning A; Geersing TH; Crul M Int J Pharm Pract; 2020 Feb; 28(1):66-74. PubMed ID: 31489970 [TBL] [Abstract][Full Text] [Related]
5. [Investigation on occupational exposure to 5-fluorouracil in pharmacy intravenous admixture service of a hospital]. Huang YW; Zhang NH; Tong DM; Feng X; Zhang MB; He JL Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Jun; 28(6):414-7. PubMed ID: 21033150 [TBL] [Abstract][Full Text] [Related]
6. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation. Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041 [TBL] [Abstract][Full Text] [Related]
7. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 66 Canadian hospitals: A 2016 follow-up study. Roland C; Caron N; Bussières JF J Occup Environ Hyg; 2017 Aug; 14(8):661-669. PubMed ID: 28574754 [TBL] [Abstract][Full Text] [Related]
8. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device. Sessink PJ; Connor TH; Jorgenson JA; Tyler TG J Oncol Pharm Pract; 2011 Mar; 17(1):39-48. PubMed ID: 20156932 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of surface contamination in a hospital hematology--oncology pharmacy. Touzin K; Bussières JF; Langlois E; Lefebvre M J Oncol Pharm Pract; 2009 Mar; 15(1):53-61. PubMed ID: 18772214 [TBL] [Abstract][Full Text] [Related]
10. Exposure to antineoplastic drugs in two UK hospital pharmacy units. Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878 [TBL] [Abstract][Full Text] [Related]
11. Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device. Guillemette A; Langlois H; Voisine M; Merger D; Therrien R; Mercier G; Lebel D; Bussières JF J Oncol Pharm Pract; 2014 Dec; 20(6):426-32. PubMed ID: 24395542 [TBL] [Abstract][Full Text] [Related]
12. Quantification of healthcare workers' exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study. Palamini M; Dufour A; Therrien R; Delisle JF; Mercier G; Gagné S; Caron N; Bussières JF J Oncol Pharm Pract; 2020 Dec; 26(8):1864-1870. PubMed ID: 32138611 [TBL] [Abstract][Full Text] [Related]
13. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757 [TBL] [Abstract][Full Text] [Related]
14. Multicenter study of environmental contamination with antineoplastic drugs in 36 Canadian hospitals: a 2013 follow-up study. Berruyer M; Tanguay C; Caron NJ; Lefebvre M; Bussières JF J Occup Environ Hyg; 2015; 12(2):87-94. PubMed ID: 25105559 [TBL] [Abstract][Full Text] [Related]
15. Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel? Labrèche F; Ouellet C; Roberge B; Caron NJ; Yennek A; Bussières JF Int Arch Occup Environ Health; 2021 Nov; 94(8):1877-1888. PubMed ID: 34410477 [TBL] [Abstract][Full Text] [Related]
16. Exposure of pharmacy technicians to antineoplastic agents: reevaluation after additional protective measures. Sessink PJ; Wittenhorst BC; Anzion RB; Bos RP Arch Environ Health; 1997; 52(3):240-4. PubMed ID: 9169636 [TBL] [Abstract][Full Text] [Related]
17. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning. Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485 [TBL] [Abstract][Full Text] [Related]
18. Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo. Schierl R; Masini C; Groeneveld S; Fischer E; Böhlandt A; Rosini V; Paolucci D J Oncol Pharm Pract; 2016 Feb; 22(1):37-45. PubMed ID: 25227229 [TBL] [Abstract][Full Text] [Related]
19. Environmental assessment of cytotoxic drugs in the Oncology Center of Cyprus. Soteriades ES; Economidou SC; Tsivitanidou A; Polyviou P; Lorimer A; Katodritis N; Theophanous-Kitiri S PLoS One; 2020; 15(3):e0216098. PubMed ID: 32134912 [TBL] [Abstract][Full Text] [Related]
20. Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Sessink PJ; Van de Kerkhof MC; Anzion RB; Noordhoek J; Bos RP Arch Environ Health; 1994; 49(3):165-9. PubMed ID: 8185386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]